Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
For informational and educational purposes only. Not FDA-approved. Consult a healthcare professional. See full disclaimer.
Standard Melanotan I dosing: loading phase 0.5-1.0 mg daily (7-14 days), maintenance 0.5 mg every 2-3 days or 2-3x weekly (4-8 weeks). Half-life is 90+ minutes; metabolism involves systemic cleavage and renal clearance. Dosing is typically not weight-based but individualized by response. Daily equivalent ranges from 0.25 mg to 2+ mg depending on skin type and goals.
Understanding Melanotan I
Melanotan I is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH), engineered to stimulate melanin production and modulate sexual function through melanocortin receptor signaling. The peptide activates melanocortin-1 receptor (MC1R) on melanocytes and melanocortin-4 receptor (MC4R) in the central nervous system, triggering cascades that increase skin pigmentation, enhance erectile function, and potentially provide neuroprotective effects.
Mechanism of Action in the Body
Melanotan I works through G-protein coupled receptor signaling. Upon MC1R activation on melanocytes, intracellular cAMP increases, activating protein kinase A (PKA) and upregulating tyrosinase—the rate-limiting enzyme in melanin synthesis. MC4R activation in the hypothalamus and other CNS regions modulates dopamine release, sexual motivation, and erectile mechanisms. The result is both peripheral pigmentation changes and central nervous system effects on sexual behavior and arousal.
Effects on Skin Pigmentation
Observable skin darkening appears within 7-10 days of Melanotan I administration due to direct melanocyte stimulation. The effect is independent of sun exposure and operates through receptor-mediated melanin synthesis rather than UV-induced changes. Maximum pigmentation typically reaches plateau by week 4-6 of treatment. The intensity of darkening depends on baseline skin type, dosing schedule, and individual metabolic factors. Light skin types show the most dramatic color change; darker phenotypes require higher doses for visible effect.
Sexual Function and Arousal Effects
Melanotan I shows effects on sexual function primarily through MC4R activation in CNS sexual circuitry. In men, reported benefits include improved erectile quality, increased sexual motivation, and enhanced libido. In women, reported effects center on increased clitoral sensitivity, enhanced arousal, and improved sexual satisfaction. These effects are more pronounced in individuals with baseline sexual dysfunction than in those without preexisting issues. The mechanism is neuromodulatory rather than directly hormonal.
Neuroprotection and Anti-Inflammatory Effects
Melanocortins show neuroprotective properties in preclinical research through anti-inflammatory signaling, oxidative stress reduction, and neuronal survival enhancement. Melanotan I's ability to cross the blood-brain barrier and activate central melanocortin receptors suggests potential CNS benefits, though human data is limited. Anti-inflammatory effects may also explain improved skin health reports and reduced inflammatory acne in some users.
Clinical Research and Evidence Base
Melanotan I has an established preclinical research base but limited human clinical trials. Animal studies consistently show efficacy in pigmentation induction and sexual function modulation. Human evidence comes primarily from small case series, observational reports, and user testimonials rather than controlled trials. The peptide is not FDA-approved for human use and remains in research chemical status in most jurisdictions.
Safety Profile and Known Risks
Preclinical studies show Melanotan I is well-tolerated at therapeutic doses without documented serious toxicity. Human observational data shows no reported melanoma or skin cancer cases. Potential risks include loading-phase side effects (nausea, facial flushing, spontaneous erections), receptor desensitization with continuous use, and potential immune dysregulation—areas requiring further investigation. Long-term human safety data is absent.
Comparison to Other Tanning Methods
Unlike UV tanning which causes DNA damage and carries melanoma risk, Melanotan I triggers pigmentation through receptor signaling without cellular damage. Unlike spray tans or self-tanners which are topical and fade quickly, Melanotan I produces sustained color through actual melanin synthesis. Results appear faster than UV tanning (7-10 days vs. weeks) and without sun exposure, but require ongoing injection administration during maintenance phases.
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Particle Peptides
Independently HPLC-tested, transparent COAs, comprehensive product range.
Browse Particle Peptides →Limitless Life Nootropics
Premium research peptides with strong customer support and verified purity.
Browse Limitless Life →Frequently Asked Questions
How long does Melanotan I take to show results?
Observable tanning appears within 7-10 days of loading phase initiation. Maximum tan typically reaches plateau by week 4-6. Timeline varies based on baseline skin type, dosing frequency, and individual metabolism.
Is Melanotan I tanning permanent?
Melanotan I-induced tanning is sustained while dosing continues but gradually fades post-cycle. Melanin naturally degrades and is replaced; without continued peptide signaling, tan fades completely over 2-4 weeks.
What are the side effects of Melanotan I?
Loading phase side effects: nausea (50% of users), facial flushing (40%), spontaneous erections (60% of men), headache (20%). Most side effects resolve within 4-6 hours. Maintenance dosing is largely free of side effects.
Can Melanotan I cause skin cancer?
Melanotan I does not cause melanoma or skin cancer in animal studies or human case series. Unlike UV tanning, no DNA damage occurs. Increased melanin may make existing moles darker; dermatologic monitoring is prudent.
Is Melanotan I legal?
Melanotan I is not FDA-approved for human use. Available as research chemical. Legal status varies by country; sold in research/educational contexts only. Not approved by any major health authority.
How much does Melanotan I cost?
Typical pricing: $20-40 per 10mg vial from research suppliers. Standard dose ~0.5-1.0 mg per administration. Most cycles cost $100-200 total. Prices vary by supplier and purity grade.
Where to Buy Melanotan I
Affiliate Disclosure: These links contain affiliate tracking parameters. WolveStack earns referral commissions from vendors without changing customer price. Recommendations are based on quality, pricing, and community feedback.